Details for Patent: 11,400,092
✉ Email this page to a colleague
Which drugs does patent 11,400,092 protect, and when does it expire?
Patent 11,400,092 protects INREBIC and is included in one NDA.
This patent has thirteen patent family members in thirteen countries.
Summary for Patent: 11,400,092
| Title: | Methods of treating myeloproliferative disorders |
| Abstract: | The present disclosure provides methods of mitigating thiamine deficiency. |
| Inventor(s): | Berry; Tymara (Morristown, NJ), Hood; John (Del Mar, CA), Jamieson; Catriona (La Jolla, CA), Scribner; Curtis L. (Oakland, CA) |
| Assignee: | Impact Biomedicines, Inc. (Summit, NJ) |
| Application Number: | 17/560,373 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 11,400,092
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-myers | INREBIC | fedratinib hydrochloride | CAPSULE;ORAL | 212327-001 | Aug 16, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATING ADULT PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK PRIMARY OR SECONDARY MYELOFIBROSIS, MONITORING THIAMINE LEVELS AND ADMINISTERING THIAMINE OR A THIAMINE EQUIVALENT | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,400,092
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019346521 | ⤷ Try a Trial | |||
| Brazil | 112021005518 | ⤷ Try a Trial | |||
| Chile | 2021000744 | ⤷ Try a Trial | |||
| China | 113286584 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 202190844 | ⤷ Try a Trial | |||
| European Patent Office | 3856169 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
